Journal Article Ppublish
PubMed: 36345367 DOI: 10.1016/j.ijregi.2022.10.007
Diagnosis of SARS-CoV-2 infection from breath - a proof-of-concept study.
IJID Reg 5:163-164
Authors: Bulemba Katende, Lucia González Fernández, Josephine Muhairwe, Tracy R Glass, Irene Ayakaka, Niklaus D Labhardt, Morten Ruhwald, Margaretha de Vos, Moniek Bresser, Klaus Reither
Affiliations
- SolidarMed, Partnerships for Health, Maseru, Lesotho.
- SolidarMed, Partnerships for Health, Lucerne, Switzerland.
- Swiss Tropical and Public Health Institute, Basel, Switzerland.
- University of Basel, Basel, Switzerland.
- Department of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
- FIND, the global alliance for diagnostics, Geneva, Switzerland.
Abstract
Bioaerosol capture and analysis is emerging as a non-invasive diagnostic method for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this proof-of-concept study conducted in Lesotho, we evaluated the novel and simple AL2 bioaerosol detection device in comparison to conventional nasopharyngeal sampling methods. We demonstrated for the first time that SARS-CoV-2 can be detected using the AL2 bioaerosol capture device. However, studies with a larger sample size are needed to further evaluate this bioaerosol capture device for the detection of SARS-CoV-2.
MeSH
Infections, Diagnosis, Sars Virus, Proof Of Concept Study, Covid-19, Sars-Cov-2